CharlesStewartLandisMD

Gastroenterology • Seattle, WA

Hepatology & Liver Transplantation

Assistant Professor, Medicine, University of Washington School of Medicine

Join to view full profile

Dr. Landis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Landis' full profile

Already have an account?

Office
125 16th Ave E
Seattle, WA 98112
Phone+1 206-326-3000

Fax+1 877-515-2975

Education & Training

University of WashingtonFellowship, Transplant Hepatology, 2009 - 2010
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Gastroenterology, 2006 - 2009
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2002 - 2004
State University of New York Downstate Medical Center College of MedicineClass of 2002

Certifications & Licensure

WA State Medical License 2009 - 2025
NY State Medical License 2005 - 2020
American Board of Obesity Medicine Obesity Medicine

Clinical Trials

Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients Start of enrollment: 2011 Oct 01
Completed
Phase 2
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Start of enrollment: 2013 Feb 01
Completed
Phase 3
Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis Start of enrollment: 2013 Aug 01
Completed
Phase 2
Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
Completed
Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis Start of enrollment: 2015 Jun 01
Completed
Phase 2
Evaluation of HepQuant SHUNT to Assess Liver Disease; Substudy Within GS-US-416-2124 Start of enrollment: 2016 Jul 31
Withdrawn
Early Phase 1
Join now to see all

Publications & Presentations

PubMed

630 citations
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton, Gregory T. Everson, Steven L. Flamm, Princy Kumar, Charles Landis
Gastroenterology. 2015-09-01
8 citations
A Randomized, Dose-Finding, Proof-of-Concept Study of Berberine Ursodeoxycholate in Patients With Primary Sclerosing Cholangitis.
Kris V Kowdley, Lisa Forman, Bertus Eksteen, Nadege Gunn, Vinay Sundaram
The American Journal of Gastroenterology. 2022-11-01
176 citations
The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Michael Trauner, Aliya Gulamhusein, Bilal Hameed, Stephen H. Caldwell, Mitchell L. Shiffman
Hepatology. 2019-09-01

Journal Articles

Can We Mitigate the Effects of Simultaneous Liver‐Kidney Transplantation Through Increased Utilization of HCV Positive Donors?
C K Johnson, J D Perkins, C S Landis, L Sibulesky, American journal of transplantation